French Pharma Stock News

Rubis earnings spark fresh look at the stock Rubis (ENXTPA:RUI) just posted half year 2026 earnings that showed higher sales, net income and earnings per share compared with the same period in 2025, giving investors fresh numbers to reassess the stock. The earnings release has landed alongside a sharp pick up in interest in Rubis, with the share price at €35.96 after a 1-day share price return of 3.10% and a 7-day share price return of 6.45%. The year-to-date share price return of 10.99%...

Sanofi (ENXTPA:SAN) has updated investors on its share capital, publishing the total number of issued shares and voting rights as of 31 August 2026 in line with French regulatory requirements. Sanofi’s share price has slipped over recent months, with the 7 day and 90 day share price returns both declining roughly 4% and 3% respectively. The year-to-date move is down 11%, yet the 5 year total shareholder return remains positive at about 11%. Benchmark Sanofi’s recent share price slide against...

Legrand stock has put in a strong run over the past few years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and standard market multiples currently point to an expensive entry point relative to that history. Investors looking at Legrand today are weighing those stretched valuation signals against a share price that has already rewarded patience over the medium term. Over the past 3 years, Legrand has delivered a 70.0% return, which sets a high bar for any new upside case...

In September 2026, Sopra Steria announced a partnership with German software vendor VMRay, integrating its advanced malware and phishing analysis into security operations centres in France and Norway, where it already processes close to 1,000 suspicious files each month for major clients. The link to VMRay, supported by Sopra Steria’s indirect shareholding via Tikehau Capital, deepens its European cyber ecosystem and gives the group greater influence over product roadmaps, integration and...

Christian Dior was caught in a broad pullback in French luxury stocks after French 10-year government bond yields reached 4.1% and concerns persisted over demand from China. The reaction highlights how closely Dior’s valuation and investor expectations are tied to sector-wide sentiment on global high-end spending, rather than company-specific news alone. We will now look at how this sector-driven pressure from rising French bond yields might influence Christian Dior’s broader investment...

Vetoquinol reported half year 2026 figures with sales of €259.3 million and net income of €30.5 million, both above the prior period, following Board approval of the reviewed financial statements. Management highlighted a return to growth, stronger profitability, solid cash generation, and preparation for several upcoming product launches. Together, these factors illustrate how Vetoquinol is leaning into its Essential products portfolio as a core earnings engine. The focus now turns to how...

Nexans (ENXTPA:NEX) has drawn fresh attention after launching a €500 million senior unsecured bond offering. The notes are due September 4, 2031, and the move raises questions about capital structure and funding priorities. The fresh bond announcement comes after a choppy few months for Nexans. The share price is now at €142.2, with recent 1-week and 1-day returns of 4.10% and 2.16%, which suggests that momentum may be starting to pick up again. Scan how Nexans compares on funding strength...

Vivendi reported half year 2026 results with sales of €140 million and net income of €28 million, both slightly below the prior period, while basic and diluted EPS from continuing operations held steady at €0.03. The small gap between sales and profit performance suggests cost discipline helped Vivendi keep earnings per share flat despite softer revenue. We will now look at how Vivendi's steady €0.03 EPS from continuing operations could shape the broader investment narrative from here. Scan...

Broker Upgrade Puts SPIE Stock Back in Focus Jefferies has upgraded SPIE (ENXTPA:SPIE) following a period of share price weakness, highlighting expectations for organic growth supported by German high-voltage projects and improving French fiber and Building Solutions activity. SPIE’s share price has slipped around 9% year to date and is down roughly 6% over the past month. The recent upgrade therefore arrives as the stock shows weaker short term momentum, despite a three year total...

What Capgemini’s new ESOP and buyback decision means for investors Capgemini (ENXTPA:CAP) has paired its thirteenth Employee Share Ownership Plan with Board approval for a dedicated share buyback envelope. This move directly addresses dilution from a capital increase of up to 3,000,000 shares. This twin decision matters for anyone watching the stock’s capital structure. Employee ownership influences incentives and culture. Targeted repurchases shape how that ownership actually shows up in the...

SES (ENXTPA:SESG) has rolled out SES CORE, a content orchestration and hybrid delivery platform that allows broadcasters to route and supervise video over satellite, fiber, and IP through a single interface. The launch of SES CORE lands at a time when SES’s recent 1 day share price return of 2.69% comes after a tougher spell, with the 30 day share price return down 12.67% and the 90 day move down 42.52%. The 1 year total shareholder return is down 16.71%, pointing to pressure that product...

Hermès International Société en commandite par actions has seen its share price retreat sharply this year, while the broader valuation checks still paint a picture of a premium stock rather than a clear bargain. For investors watching a luxury leader with a long runway story, the question is whether that recent pullback has done enough work on the price. Year to date, Hermès International Société en commandite par actions has fallen about 33.5%, which is a sizeable reset for a high-end...

Schneider Electric has widened its reach in Korea's AI data center market as CK Solution becomes an authorized distributor of its power, cooling, and automation solutions, integrating these with CK's existing HVAC and construction capabilities. The arrangement gives Schneider Electric deeper access to data center build projects in Korea, linking its energy management hardware and software directly into CK Solution's design pipeline rather than relying only on standalone product sales. This...

As you might know, Séché Environnement SA ( EPA:SCHP ) recently reported its half-yearly numbers. Results overall were...

Oil hovering near $100 and European gas around €80/MWh are shaking up inflation expectations and forcing the ECB to talk tougher on interest rates. That combination can reorder winners and losers across energy and rate sensitive sectors, and investors who react late often watch from the sidelines. This article walks through three integrated European oil and gas stocks exposed to these shifting forces and explains how they could matter for a diversified portfolio today. The stocks covered...

TotalEnergies (ENXTPA:TTE) plans to bring the new Acacia-5 oil discovery on Angola's Block 17 into production within three months. The group intends to use existing FPSO facilities on Block 17 to accelerate Acacia-5 deployment instead of building new infrastructure. TotalEnergies has expanded its Angolan portfolio by acquiring operated interests in exploration Blocks 17/25 and 32/21 in the Lower Congo Basin. The rapid Acacia-5 start up and new Angola blocks matter, but investors should weigh...

Aeroports de Paris (ENXTPA:ADP) has drawn attention after its recent trading left the shares at €108.90, with returns mixed across short and longer periods and a modest gain over the past 3 years. Recent trading reflects that pattern, with Aeroports de Paris posting a 1-day share price return of 0.55% and a 30-day share price return that is down 4.72%, while the 1-year total shareholder return has slipped 0.90% and the 5-year total shareholder return is up 20.14%. Compare Aeroports de Paris...

Soitec (ENXTPA:SOI) raised its earnings guidance for the second quarter of fiscal 2027, telling investors it now targets about 50% year-on-year revenue growth instead of the previously flagged more than 30%. Soitec shares trade at €141.15 after a 3.37% one-day share price return and a 10.02% seven-day share price return, adding to a very large year-to-date share price gain of about 4.7x that appears linked to the upgraded revenue outlook. However, the three-year and five-year total...

Roche Bobois stock has been under pressure, with the share price down about 20% over the past three months and roughly 8% over the past month. The latest half year report did not change that mood. H1 2026 revenue came in at €187.8 million and net income at €3.3 million, keeping the trailing net profit margin around 2%, below last year’s 3.2% level. The short term story is a luxury furniture group experiencing thinner profitability. The longer term question is whether a business priced on a...

Accor expansion in Egypt puts growth plans in focus Accor (ENXTPA:AC) is in the spotlight after outlining plans to add around 25,000 hotel rooms in Egypt over the next three years and explore a specialised hospitality academy. Management discussed these expansion plans with Egyptian Prime Minister Mostafa Madbouly, alongside government support for a broader set of Accor brands and refurbishment of existing luxury properties with local investor partnerships. These Egypt plans arrive as Accor’s...

Airbus stock presents a tricky mix right now, with a strong 5 year gain already on the table while several valuation checks still flag the shares as cheap relative to an intrinsic value estimate and to market multiples. The share price has returned 92.3% over 5 years, which means anyone looking at Airbus today is assessing a company that has already delivered a sizeable long term gain. Fresh aircraft orders in both passenger and freighter markets may support expectations for future cash...

Sanofi (ENXTPA:SAN) is expanding its commercial leadership for the Nuvaxovid COVID-19 vaccine targeting the new XFG variant for the 2026-2027 season. The rollout focuses on key markets including the U.S., European Union, and Japan, with further launches planned in Germany, Canada, and additional countries. The Nuvaxovid agreement structure broadens commercial reach for the vaccine within Sanofi's wider vaccines portfolio and global distribution network. The expanded Nuvaxovid XFG rollout...

Vetoquinol stock has quietly added double digit gains over the past three months, yet the latest move hinges on one key idea: margin credibility. H1 2026 revenue landed at €259.3 million, broadly steady, while net income reached €30.5 million. That keeps trailing net profit margin close to 12%, a rare pocket of stability in animal health where input costs can easily squeeze profitability. The market is reacting to that resilience as much as the headline earnings line, rewarding a business...

Sogeclair entered this earnings season with a reputation as a quietly cheap aerospace and defense stock. The price is still around €32.4 and the 30 day return is down about 4%, even as trailing 12 month earnings from continuing operations sit near €7.977 million and the stock trades on a reported P/E of 14.6x that is well below sector averages. The headline from this half year release is not rapid revenue growth but a profit picture that remains intact, which keeps the valuation gap in sharp...